Proportion of TB infection diagnosis by study period and BCG-vaccination status.

<p>Proportion of TB infection diagnosis by study period and BCG-vaccination status.</p

Final disposition and incidence of active TB by study period.

<p>Final disposition and incidence of active TB by study period.</p

Chart of the contacts included.

<p>TB: tuberculosis; HIV: human immunodeficiency virus; MDR: multi-drug resistant; ESRD: end-stage renal disease; TST: tuberculin skin test; NTM: Non-tuberculous mycobacteria. ^a12 and 6 patients in the first and second period, respectively.</p

TST and QFT-GIT results of BCG-vaccinated patients in the second period.

<p>TST and QFT-GIT results of BCG-vaccinated patients in the second period.</p

Monthly distribution of LP group and non-LP group patients.

<p>Monthly distribution of LP group and non-LP group patients.</p

Cases of sporadic LP admitted to our hospital from 1995 through 2011.

<p>Cases that occurred during each monthly reporting period are shown in the line graph, while average rainfall is shown in the bar graph.</p

Factors associated with mortality in patients with COPD and pneumonia: univariate analysis.

<p>DM, diabetes mellitus; FEV1: Forced expiratory volume in the first second; ICU: Intensive care unit; IQR, interquartile range; PSI, pneumonia severity index.</p>1<p>Data available only for 52 patients and 790 patients respectively; ²Patients were stratified into the following risk classes according to the PSI score: low risk (≤90 points, classes I, II, and III) and high risk (>90 points, classes IV and V).</p><p>Factors associated with mortality in patients with COPD and pneumonia: univariate analysis.</p

Factors associated with mortality in patients with COPD and pneumonia: multivariate analysis.

<p>COPD, chronic obstructive pulmonary disease; OR: odds ratio; PSI, pneumonia severity index.</p><p>Factors associated with mortality in patients with COPD and pneumonia: multivariate analysis.</p